Langeais, FR – Sylvan, a leading manufacturer of fungal biotechnology solutions, today announces the acquisition of French agaricus mushroom spawn producer EuroMycel from Bonduelle (BON.PA). The acquisition strengthens Sylvan’s position in the edible fungi market, expanding its capacity and capabilities in spawn production in Europe. Pending final legal approvals, the transaction is expected to close by the end of 2024.
Enhancing capabilities and expanding capacity
The acquisition of EuroMycel allows Sylvan to tap into additional production capacity which it requires as part of the rollout of their Strategy 2028, which will see an increased focus on the commercialisation of patented new strains and fungal solutions. EuroMycel, known for its high quality agaricus strains and expertise in grain-based spawn production, will enhance Sylvan’s ability to serve the rapidly growing demand for its products in the European market and beyond.
“We are excited to welcome Frédéric and the EuroMycel team to the Sylvan organisation. The company has built an excellent reputation as a supplier of reliable high-performance spawn, and they will continue to operate independently under the existing leadership team. We cannot wait to start the process of sharing scientific knowledge and expertise across the businesses.” said Iwan Brandsma, Sylvan Europe CEO and Group Chief Growth Officer. “This acquisition is a significant step forward in the delivery of our Strategy 2028 ambitions.”
A shared vision
Founded in 1992, EuroMycel specialises in the production of spawn for edible mushrooms. The company was acquired by Bonduelle in 2010. With a team of 40 employees, the company has established itself as a key player in the European market, offering best-in-class solutions to their clients.
EuroMycel Managing Director, Mr. Frédéric Mathieu, said: “Under the leadership and unwavering support of the Bonduelle Group, a remarkable 14 years of EuroMycel’ s history is closing. The executive team are excited to continue the positive development of the business alongside Sylvan, the world number 1 in mushroom spawn production. This transaction will support the ongoing growth of the L’Île Bouchard plant, and our shared vision and R&D capabilities will bring even greater opportunities to our clients and our employees.”